CN Patent

CN102119217A — 用于核酸递送的新型制剂

Assigned to Wild Strawberry Bio Pharmaceutical Co · Expires 2011-07-06 · 15y expired

What this patent protects

本发明提供包含一种或多种活性剂或治疗剂的新型稳定的脂质颗粒，制备所述脂质颗粒的方法，和递送和/或施用所述脂质颗粒的方法。更具体地，本发明提供包含核酸(诸如一种或多种干扰RNA)的稳定核酸-脂质颗粒(SNALP)，制备SNALP的方法，和递送和/或施用SNALP的方法。

USPTO Abstract

本发明提供包含一种或多种活性剂或治疗剂的新型稳定的脂质颗粒，制备所述脂质颗粒的方法，和递送和/或施用所述脂质颗粒的方法。更具体地，本发明提供包含核酸(诸如一种或多种干扰RNA)的稳定核酸-脂质颗粒(SNALP)，制备SNALP的方法，和递送和/或施用SNALP的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN102119217A
Jurisdiction
CN
Classification
—
Expires
2011-07-06
Drug substance claim
No
Drug product claim
No
Assignee
Wild Strawberry Bio Pharmaceutical Co
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.